Swiss stocks - Factors to watch on Nov 17


Nov 17 The Swiss blue-chip SMI was seen opening 0.2 percent higher at 7,931 points on Thursday, according to premarket indications by bank Julius Baer . Roche and Bristol-Myers Squibb on Thursday became the latest drugmakers to cut the price of cancer medicines in order to secure access to Britain's National Health Service.



from Biotech News